The functional Thr130Ile and Val255Met polymorphisms of the hepatocyte nuclear factor-4α (HNF4A):: Gene associations with type 2 diabetes or altered β-cell function among Danes

被引:31
作者
Ek, J
Rose, CS
Jensen, DP
Glümer, C
Borch-Johnsen, K
Jorgensen, T
Pedersen, O
Hansen, T
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] Hagedorn Res Inst, DK-2820 Gentofte, Denmark
[3] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark
[4] Aarhus Univ, Fac Hlth Sci, DK-8000 Aarhus, Denmark
关键词
D O I
10.1210/jc.2004-2159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HNF4A encodes an orphan nuclear receptor that plays crucial roles in regulating hepatic gluconeogenesis and insulin secretion. The aim of the present study was to examine two rare missense polymorphisms ofHNF4A, Thr130Ile and Val255Met, for altered function and for association with type 2 diabetes (T2D). We have examined these polymorphisms 1) by in vitro transactivation studies and 2) by genotyping the variants in 1409 T2D patients and in 4726 glucose-tolerant Danish white subjects. When tested in COS7 cells, both the Thr130Ile and the Val255Met variants showed a significant decrease in transactivation activity compared with wild-type (73% of wild-type, P = 0.02, and 76%, P = 0.04, respectively). The Thr130Ile variant had a significantly increased carrier frequency among T2D patients compared with glucose-tolerant subjects [ odds ratio, 1.26 (1.01 - 1.57); P = 0.04]. The rare Val255Met polymorphism had a similar frequency among T2D patients and glucose-tolerant subjects. Heterozygous glucose-tolerant carriers of the variant showed, however, decreased levels of fasting serum C-peptide (76%; P = 0.03) and decreased fasting serum triglyceride ( 58%; P = 0.02). In conclusion, The Thr130Ile and the Val255Met polymorphisms decrease the transcriptional activity of HNF4A, and the Thr130Ile polymorphism associates with T2D, whereas the Val255Met variant associates with a decrease in fasting serum C-peptide.
引用
收藏
页码:3054 / 3059
页数:6
相关论文
共 53 条
  • [1] The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
    Altshuler, D
    Hirschhorn, JN
    Klannemark, M
    Lindgren, CM
    Vohl, MC
    Nemesh, J
    Lane, CR
    Schaffner, SF
    Bolk, S
    Brewer, C
    Tuomi, T
    Gaudet, D
    Hudson, TJ
    Daly, M
    Groop, L
    Lander, ES
    [J]. NATURE GENETICS, 2000, 26 (01) : 76 - 80
  • [2] Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4α
    Bartoov-Shifman, R
    Hertz, R
    Wang, HY
    Wollheim, CB
    Bar-Tana, J
    Walker, MD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) : 25914 - 25919
  • [3] A transcription factor regulatory circuit in differentiated pancreatic cells
    Boj, SF
    Párrizas, M
    Maestro, MA
    Ferrer, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) : 14481 - 14486
  • [4] Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy
    Bowden, DW
    Sale, M
    Howard, TD
    Qadri, A
    Spray, BJ
    Rothschild, CB
    Akots, G
    Rich, SS
    Freedman, BI
    [J]. DIABETES, 1997, 46 (05) : 882 - 886
  • [5] High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
    Buetow, KH
    Edmonson, M
    MacDonald, R
    Clifford, R
    Yip, P
    Kelley, J
    Little, DP
    Strausberg, R
    Koester, H
    Cantor, CR
    Braun, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (02) : 581 - 584
  • [6] A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young
    Bulman, MP
    Dronsfield, MJ
    Frayling, T
    Appleton, M
    Bain, SC
    Ellard, S
    Hattersley, AT
    [J]. DIABETOLOGIA, 1997, 40 (07) : 859 - 862
  • [7] CLONING AND SEQUENCING OF CDNAS ENCODING THE HUMAN HEPATOCYTE NUCLEAR FACTOR 4 INDICATE THE PRESENCE OF 2 ISOFORMS IN HUMAN LIVER
    CHARTIER, FL
    BOSSU, JP
    LAUDET, V
    FRUCHART, JC
    LAINE, B
    [J]. GENE, 1994, 147 (02) : 269 - 272
  • [8] Crystal structure of the HNF4α ligand binding domain in complex with endogenous fatty acid ligand
    Dhe-Paganon, S
    Duda, K
    Iwamoto, M
    Chi, YI
    Shoelson, SE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) : 37973 - 37976
  • [9] Drewes T, 1996, MOL CELL BIOL, V16, P925
  • [10] Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
    Ek, J
    Andersen, G
    Urhammer, SA
    Gæde, PH
    Drivsholm, T
    Borch-Johnsen, K
    Hansen, T
    Pedersen, O
    [J]. DIABETOLOGIA, 2001, 44 (12) : 2220 - 2226